PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA

Authors :: A. Pages
L. Molinier
F. Puisset
S. Bertoli
M. pierre-Luc
L. Cabrit
C. Recher
Source :: Value in Health. 23:S132
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Health Policy
Public Health, Environmental and Occupational Health
chemistry.chemical_element
Cost-effectiveness analysis
medicine.disease
First line treatment
Leukemia
chemistry
Internal medicine
medicine
business
Arsenic

Tools